Leadership Team2019-12-02T18:16:23+00:00
COMPANY

Leadership Team

COMPANY

Leadership
Team

Improving the quality of healthcare worldwide

Committed to providing high quality, reliable, cutting-edge tools for molecular diagnostic and personalized molecular medicine.

Committed to improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge tools for molecular diagnostic and personalized molecular medicine.

JEFFREY EDWARD MILLER, PH.D.
JEFFREY EDWARD MILLER, PH.D.
FOUNDER, CHIEF SCIENTIFIC OFFICER, CHIEF EXECUTIVE OFFICER & CHAIRMAN

Dr. Miller is a scientist, inventor, entrepreneur focused on Improving Lives with Precision Diagnostics® – coupling drug trials and therapeutic treatment regimens with optimized clinically-actionable diagnostic methods in order to select the correct patients and then monitor and track their response throughout the course of their disease. He received his undergraduate degree in Biochemistry from UCLA and a combined Ph.D. in Biochemistry & Molecular Biology from UCSB.
Prior to starting Invivoscribe, Dr. Miller had more than twenty years of combined experience in protein biochemistry, cellular and molecular immunology, cardiac physiology, virology, and molecular biology, experience he had developed working in laboratories at the Medical School, Department of Chemistry, Molecular Biology Institute at UCLA, while earning his Ph.D. at UCSB, and as a postdoctoral scientist at Applied Molecular Evolution. He also spent several years at Quest Diagnostics Nichols Institute, setting up the molecular oncology laboratory and developing and launching PCR-based molecular assays for infectious disease and hematopathology.
Dr. Miller has a number of patents, peer-reviewed publications, and he has contributed to chapters in textbooks. He has been a member of the Association for Molecular Pathology for more than two decades, and is a member of ASH, EHA, and ASCO.
MEGHNA BHATNAGAR
MEGHNA BHATNAGAR
CHIEF FINANCIAL OFFICER

Meghna Bhatnagar joined Invivoscribe in 2010 as Chief Financial Officer. In this role she is responsible for leading the Invivoscribe global finance organization, along with human resources and information technology.
Meghna Bhatnagar joined Invivoscribe in 2010 as Chief Financial Officer. In this role she is responsible for leading the Invivoscribe global finance organization, along with human resources and information technology.
Since her arrival, Ms. Bhatnagar has played an integral role in directing all aspects of company strategy, planning and operations.
Ms. Bhatnagar has over 20 years of experience building and leading finance and IT teams in global companies. Prior to joining IVS, she served as COO of Radiant Technologies, a technology company focused on providing business management solutions to small and medium sized companies where she was responsible for leadership and development of an entire project delivery team with full P&L responsibility. She played a key role in guiding overall strategy of the company and at the same time provided leadership for operational improvements.
Ms. Bhatnagar began her career in at Nunhems Seeds, a company of Bayer AG. During her tenure at Bayer she managed comprehensive portfolio of responsibilities in Finance and Information Technology both at regional and global levels.
Ms. Bhatnagar graduated from Kurukshetra University in India with bachelor’s degree in Accounting and earned a MBA from MDI, a premier business school in India.
DR. BRADLEY PATAY, M.D.
DR. BRADLEY PATAY, M.D.
CHIEF MEDICAL OFFICER

Dr. Patay is dedicated to improving health by integrating genomic knowledge into medical care. He has authored numerous articles in this field, presented at multiple conferences and has been featured in Bloomberg Business Week.
Dr. Patay is dedicated to improving health by integrating genomic knowledge into medical care. He has authored numerous articles in this field, presented at multiple conferences and has been featured in Bloomberg Business Week. He has been head of the internal medicine section at Scripps Torrey Pines, worked as an Assistant Professor at STSI, and has been a founding member of the Board, and Vice President of the College of Genomic Medicine, which was established in 2010 to educate physicians and other health care professionals about genomic medicine.
His diverse clinical experience prior to joining Scripps Clinic in 2005 includes four years as an internist and pediatrician at Neighborhood Healthcare, a private, nonprofit community healthcare practice, and at Palomar Hospital. At these institutions, Brad cared for a wide range of patients, from neonates to the elderly, in both intensive care and the general wards. Through his service on several committees, he helped improve the health care institutions’ systems.
Dr. Patay has also been both a principle investigator and sub-investigator on studies that have integrated genomic and phenotypic data into models that help elucidate such topics as blood pressure, longevity and cancer. He also serves on a committee that helps select patients for genome sequencing to elucidate their unknown conditions.
He graduated with honors in economics and molecular cell biology from the University of California at Berkeley and he was elected to Phi Beta Kappa. After receiving his M.D. degree at UC San Diego in 1997, he completed a medical residency at Banner Health in Phoenix, Arizona and earned board certifications in Internal Medicine and Pediatrics.
MICHAEL VISHNEVETSKY, PH.D.
MICHAEL VISHNEVETSKY, PH.D.
HEAD OF BUSINESS DEVELOPMENT

Dr. Vishnevetsky joined Invivoscribe in 2018 as the Head of Global Business Development. In this role he leads Invivoscribe’s woldwide business development efforts with focus on Pharma engagement and companion diagnostics (CDx) test development.
Dr. Vishnevetsky joined Invivoscribe in 2018 as the Head of Global Business Development. In this role he leads Invivoscribe’s woldwide business development efforts with focus on Pharma engagement and companion diagnostics (CDx) test development. Prior to joining Invivoscribe, Dr. Vishnevetsky held business development positions at Pacific Biosciences and Thermo Fisher Scientific with focus on utilization of Next Generation Sequencing (NGS) for diagnostics of rare disease and clinical oncology. While at Thermo Fisher he led development of strategic alliance program focused on diagnostic and companion diagnostic (CDx) partnerships, facilitating multiple strategic development agreements. Prior to that Dr. Vishnevetsky served and as Vice President of Sales and Marketing at WaferGen Biosystems and held sales management, marketing and corporate strategy positions of increasing responsibility at Life Technologies-Invitrogen. In addition, Dr. Vishnevetsky completed “High Potential Leadership” and “Strategic Marketing Management” programs at Harvard Business School and “Strategic Thinking and Management for Competitive Advantage” at the Wharton School.
Dr. Vishnevetsky obtained a postdoctoral appointment in biology from the California Institute of Technology (“Caltech”) and holds a PH.D. in Molecular Biology from Hebrew University of Jerusalem.
PAUL MCMULLIN
PAUL MCMULLIN
HEAD OF GLOBAL SALES & MARKETING

Paul McMullin joined Invivoscribe in 2018 as the Head of Global Sales & Marketing. In this role, he leads Invivoscribe’’s worldwide Sales and Marketing efforts with focus on both Diagnostic and Companion Diagnostics (CDx) Products. These Products are sold in over 100 Countries via a Direct Sales Organization as well as Exclusive Distributors.
Paul McMullin joined Invivoscribe in 2018 as the Head of Global Sales & Marketing. In this role, he leads Invivoscribe’’s worldwide Sales and Marketing efforts with focus on both Diagnostic and Companion Diagnostics (CDx) Products. These Products are sold in over 100 Countries via a Direct Sales Organization as well as Exclusive Distributors.
Mr. McMullin has over 35 years of experience working in the Medical Diagnostics Business. Most of that time has been in the molecular and biotechnology fields. His experience includes numerous positions in Sales and Marketing, establishing Direct Sales, Service and Support companies in Europe and Australia, and managing Distributor Sales in over 55 countries worldwide. He has directly managed employees in Japan, China and most major EU countries.
Mr. McMullin has worked in small, medium and large company settings, providing significantly increased Sales and Market Share in each case. He has routinely launched New Products into foreign countries, directed foreign country Product Registrations and led Special Project Teams in support of CE Marking, New Product Development, and New Business Development. He has initiated the licensing of Products to foreign companies, participated twice in corporate IPOs when going public and conducted numerous International Sales, Marketing and Service Meetings. Mr. McMullin is known for cultivating strong working relationships with people at all levels, both inside and outside of the company, and in working together in developing successful results. Mr. McMullin earned a Master’s Degree in International Management, graduating with honors from the American Graduate School of International Management (Thunderbird). He also holds a Bachelor’s Degree in Business Administration, graduating Magna Cum Laude, from Arizona State University.